Table 1.
Summary of the results obtained for pbest for the HCMV diseases under consideration. (The estimation of the peak parameter was determined by maximization of the variation in times to disease. The 95% confidence intervals were calculated by bootstrapping, and the significance level was determined by an F-test. NA, not applicable.).
| HCMV disease | number of patients | peak parameter (95% CI) | explained variance (%) | significance (p-value) |
|---|---|---|---|---|
| fever | 14 | 0.33 (0.014–0.44) | 84.2 | 3.8×10−6 |
| pneumonitis | 14 | 0.25 (0.12–0.34) | 50.7 | 0.0043 |
| gastrointestinal | 7 | 0.38 (0.058–0.52) | 75.6 | 0.011 |
| hepatitis | 4 | 0.11 (NA) | 46.5 | 0.32 |
| retinitis | 17 | 0.065 (NA) | 2.6 | 0.54 |